PPD Signs Agreement to Use Tessella and Berry Consultants’ Adaptive Trial Design Software »

FACTSTM software enhances PPD’s ability to deliver time- and cost-savings for clients WILMINGTON, N.C., and NEWTON, Mass. (November 14, 2012) – Pharmaceutical Product Development, LLC (PPD) has signed a license agreement to use Tessella and Berry Consultants’ FACTSTM software to create a more flexible, intuitive approach for designing both adaptive and fixed trials. The software […]

Tessella and Neusentis, a research unit of Pfizer Limited, Team Recognised for Innovative Data Analysis Technique »

Novel work analysing microneurography data wins Tessella Excellence Award A Tessella project, working with a team of Neusentis scientists from Cambridge and other Pfizer scientists from Sandwich, respectively, has been recognised for novel work analysing microneurography data with a Tessella Excellence Award in the ‘Most Innovative Work’ category. The Tessella Excellence Awards were created to […]

Delivering Innovation and Efficiency Through Adaptive Clinical Trials »

Aptiv Solutions, Berry Consultants and Tessella have partnered together to develop a one day forum to address the challenges in adopting adaptive trials in the drug, medical device and clinical research industry and assess their potential for transforming drug development. Join experts in the economics and management of the pharmaceutical industry, drug developers, and adaptive […]

Aptiv Solutions, the First CRO to License Tessella and Berry Consultants FACTS Technology »

Aptiv Solutions, a global biopharmaceutical and medical device development services company, and leader in adaptive clinical trial design, simulation and execution, announced today a collaboration with Tessella, a world leader in the provision of science powered technology and consulting services and Berry Consultants, leaders in the Bayesian approach to medical statistics, to deliver integrated early […]

New Paper from Optibrium and Tessella Illustrates Scientists’ Instincts are often Impaired by Human Cognitive Biases When Making Drug Discovery Decisions »

CAMBRIDGE | OXFORD UK, July 8 2010 – Optibrium, a provider of software solutions for drug discovery, and Tessella, the technology and consulting services company, today published a new paper highlighting that scientists’ instincts may not always lead them to making good drug discovery decisions. The challenges of decision-making arise from the importance of multiple/conflicting […]